News Home Page
Access the 15 most recent news items below. For older items, please click the 'view archives' link in the lower right.
Zika Test from Quest Diagnostics Authorized by the FDA for Emergency Use
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, recently announced that it has received a U.S. Food and Drug Administration (FDA) Emergency Use Authorization (EUA) for the Zika Virus RNA Qualitative Real-Time RT-PCR test (Zika RT-PCR test). The test was developed by the reference laboratory business of Quest's Focus Diagnostics, Inc., subsidiary. The proprietary molecular test is intended for the qualitative detection of RNA from the Zika virus in human ...
Posted on: April 29, 2016
BD and Sight Diagnostics to Introduce Malaria Detection Device
BD (Becton, Dickinson and Company) recentlyy announced a collaboration with Sight Diagnostics Ltd. (SightDX) to introduce the Parasight Malaria Detection Platform in India. Through this agreement, BD will market the Parasight Platform in the Indian diagnostics market, adding to BD's extensive infectious disease diagnostics portfolio. The collaboration will represent the first malaria diagnostics offering from BD.Varun Khanna, managing director, BD India and South Asia said, "Our collaboration with Sight ...
Posted on: April 28, 2016
Genomic Test Helps Resolve Ambiguity in Lung Cancer Diagnosis
Veracyte, Inc. (NASDAQ: VCYT), a molecular diagnostics company pioneering the field of molecular cytology, recently announced that it has received regulatory authorization from the New York State Department of Health to offer the Percepta Bronchial Genomic Classifier for patients in the state. The genomic test, commercially introduced in April 2015, is used to help patients avoid unnecessary invasive, risky and costly procedures to assess potentially cancerous lung nodules that were initially found on CT ...
Posted on: April 27, 2016
Velano Vascular Receives Additional FDA Clearance for Innovative Blood Draw Device
Velano Vascular, a medical technology company transforming and enhancing the care experience for hospitalized patients and their practitioners, announced recently that the company received U.S. Food and Drug Administration (FDA) clearance for a modified version of its novel, needle-free blood draw device. The Velano device is designed to reduce blood draw-related discomfort and anxiety for hospital inpatients, provide a safer work environment for healthcare providers, and standardize today's fragmented ...
Posted on: April 26, 2016
Uncontrolled Viral Loads: Experienced Patients Face Dwindling Pool of Effective Options
Recently, CytoDyn filed a request with the FDA for Breakthrough Therapy Designation to use PRO 140 as a treatment for HIV Infection in Treatment-Experienced Patients with Virologic Failure. The Company believes this request addresses the unmet need for novel therapies for the growing number of heavily treatment-experienced HIV patients who face a dwindling pool of effective therapeutic options in the face of uncontrolled viral load and low CD4+ T-cell counts.While the standard of care for HIV infection ...
Posted on: April 25, 2016
Aslan Pharmaceuticals Appoints Experts to Scientific Advisory Board
ASLAN Pharmaceuticals (ASLAN), a biotech company focused on the development of immunotherapies and targeted agents for Asia prevalent tumour types, recently announced the appointment of four global cancer experts to its new Scientific Advisory Board.The newly-formed Board will be chaired by eminent scientist Professor Sir David Lane, who is renowned for his contributions to cancer research, including the discovery of the p53 tumour suppressor protein. He was most recently awarded the 2012 Cancer Research ...
Posted on: April 24, 2016
Simplify Material Science Applications with the New OLYMPUS Microscope and Image Analysis Software
Simplify Material Science Applications with the New OLYMPUS Microscope and Image Analysis SoftwareCombining ease of use with expanded functionality, Olympus' new BX53M System Microscope makes it easy for users to quickly and accurately undertake a variety of analytical tasks. When combined with new OLYMPUS Stream 2.1 Image Analysis Software, the BX53M simplifies workflow from observation to measurement, analysis, and reporting. The BX53M's user-friendly upright design features easy-to-adjust aperture ...
Posted on: April 23, 2016
Singlera Genomics Joins Forces with Yale Researcher for Study
Singlera Genomics Inc., a startup company focusing on non-invasive genetic testing, recently announced the signing of a Clinical Trial Agreement with a research team led by Professor Michael J. Paidas, MD, of Yale School of Medicine. Paidas will partner with Singlera on evaluating a Singlera's proprietary technology for non-invasive prenatal testing of chromosomal aneuploidy and simultaneous measurement of fetal DNA fraction in a single test. This new method has the potential to significantly lower the ...
Posted on: April 22, 2016
Abcodia Announces Expanded U.S. Availability of Test for Early Ovarian Cancer Detection
Abcodia, a commercial stage company focused on the development of proprietary tests for the early detection of cancer, recently announced expanded U.S. availability of the ROCA Test. Following an initial U.S. launch in Arizona, Illinois, Massachusetts, New Jersey and Texas, the ROCA Test is now available in nine additional states (Georgia, Michigan, Missouri, North Carolina, Nevada, Ohio, Oregon, Virginia, Washington, Wisconsin) and the District of Columbia."We have seen strong interest in the recent data ...
Posted on: April 21, 2016
Aperio Digital Pathology Reinforces its Commitment to AACR
Leica Biosystems recently announced that, as part of its continued commitment to cancer research, it will exhibit its leading edge Aperio LV1* and Aperio VERSA* digital pathology systems, and demonstrate its new, Aperio Image Analysis Algorithms* at the ACCR meeting in New Orleans, April 16 - 20. Leica Biosystems mission to advance cancer diagnostics, improving patient's lives, is directly aligned with ACCR's 2016 focus: Delivering Cures through Cancer Science, reinforcing the inextricable link ...
Posted on: April 20, 2016
Quest Diagnostics Expands Dako's PD-L1 IHC 28-8 Test to Include Melanoma
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, recently announced it will offer clinical laboratory testing using the PD-L1 IHC 28-8 pharmDx qualitative test from Dako, an Agilent Technologies company. Earlier today, Dako announced the U.S. Food and Drug Administration (FDA) approved the complementary in vitro diagnostic test for use in the detection of PD-L1 expression in formalin-fixed, paraffin embedded (FFPE) melanoma tissue.In addition, the FDA ...
Posted on: April 19, 2016
Endocrine Society Celebrates 100 Years of Public Health Breakthroughs
A century ago, a small group of physicians banded together to unlock the secrets of the body's hormones - the chemical signals that govern breathing, metabolism, growth, reproduction and other critical biological functions. They were endocrinologists, and from this impassioned gathering, the Endocrine Society was born.Over the next 100 years, endocrinologists would discover lifesaving treatments and provide quality care for hundreds of millions of people with diabetes, osteoporosis, thyroid conditions, ...
Posted on: April 18, 2016
IASLC Foundation Receives $25,000 Donation to Spur Lung Cancer Research
The International Association for the Study of Lung Cancer (IASLC) Foundation recently accepted a gift of $25,600 to help find new and better lung cancer treatments in honor of the memory of a Denver-area lung cancer patient who recently passed away.Doctors diagnosed John F. Fisher with lung cancer in August 2015 and he passed away within a few weeks. His lung cancer diagnosis came as a shock to John and his wife, Lauren. Lauren has taken up the mantle to spread the word of John's Legacy. John's Legacy is ...
Posted on: April 17, 2016
New Study Examines Fixative Solutions Used in Skin Biopsy Test for Small Fiber Neuropathy
Therapath LLC, a leader in neuropathology, recently finalized a comparison study of the most common fixation methods used in Epidermal Nerve Fiber Density (ENFD) testing for the determination of small fiber neuropathy. The study concluded that proper fixation technique is critical for test accuracy.The study, published in Clinical Neuropathology, compared the results of immune staining on tissue shipped in PLP (2% paraformaldehyde lysine periodate) fixative and Zamboni's (2% paraformaldehyde, picric acid) ...
Posted on: April 16, 2016
Leica Biosystems and Merrimack Pharmaceuticals to Collaborate
Leica Biosystems and Merrimack Pharmaceuticals (NASDAQ: MACK) recently announced a strategic partnership to develop companion diagnostic assays to aid in identification of patients who might best respond to current and future oncology therapies developed by Merrimack. The assays will be designed using Advanced Cell Diagnostics' (ACD's) RNAscope technology and will be processed on Leica Biosystems' BOND clinical advanced staining systems. The initial focus of this partnership will be the development of a ...
Posted on: April 15, 2016